Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer.
about
Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular backgroundThe long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cellsOverexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer.Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivoLong noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.Upregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K/AKT pathway.LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability and promotes apoptosis of colorectal cancer cells.Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1α via miR-138.Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.Long intergenic non-coding RNA 00152 promotes renal cell carcinoma progression by epigenetically suppressing P16 and negatively regulates miR-205.Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma.High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression.LncRNA UCA1 promotes renal cell carcinoma proliferation through epigenetically repressing p21 expression and negatively regulating miR-495.Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.Prognostic role of long non-coding RNA LINC00152 in Chinese cancer patients: a meta-analysis.Selecting lncRNAs in gastric cancer cells for directed therapy with bioactive peptides and chemotherapy drugs.Linc00152 suppresses apoptosis and promotes migration by sponging miR-4767 in vascular endothelial cells.The prognostic effect of LINC00152 for cancer: a meta-analysis.lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214.Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p.Decreased expression of the long non-coding RNA SLC7A11-AS1 predicts poor prognosis and promotes tumor growth in gastric cancer.LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation.Long noncoding RNA DANCR is activated by SALL4 and promotes the proliferation and invasion of gastric cancer cells.The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer.Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinoma.LINC00152 is a potential biomarker involved in the modulation of biological characteristics of residual colorectal cancer cells following chemoradiotherapy.Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription.LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis.The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.Epigenetic regulation of long non-coding RNAs in gastric cancer.Dysregulated Expression of Long Intergenic Non-coding RNAs (LincRNAs) in Urothelial Bladder Carcinoma.Emerging role of long non-coding RNA in the development of gastric cancerLong non-coding RNAs involved in metastasis of gastric cancerTranscriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinomaPrognostic value of long noncoding RNAs in gastric cancer: a meta-analysis
P2860
Q26745416-49780BD7-29B5-4141-8F9D-A29D66856753Q33720269-E96D8E96-8647-41FF-B992-3EBA72F06070Q33774226-682F87DC-9F83-40FD-BE17-E854D4E031A0Q33865244-92D763D9-ED8A-48E5-B978-DAEE90CFAC81Q33888751-2DAE0DD6-13E3-4BC0-A3AF-5E52A873CF6AQ37393385-1258A0DC-C897-49E9-9315-E782FAD6AA92Q37553737-F01EBD07-67AD-45C8-BCE2-082C1AA19114Q37597116-A0AA148C-2FD1-4E1E-9D71-B6DF5AB09BFBQ37637102-B6F5098C-4DBD-40C3-A304-48BF0F1C7018Q37649185-5C00E3B1-B02D-46F4-9673-BFA6CA01C7F4Q37680005-50DE7F9F-A750-4E68-8ADE-FB4BA54D2011Q37693413-40AC5A45-1C63-45CB-B62D-FB73551FD7F9Q38700224-317340BD-6045-4AD5-B4E3-BEF546CF90E3Q38705111-9049DE79-0AF9-4A51-87AD-49B29108E998Q38740450-38F35564-8220-43EA-925F-BD65403C019FQ39254523-28940E1E-06DA-4682-9B08-B88155F6CD17Q39340502-FF3DD971-C02A-4383-8FD0-E96C557122E1Q41035804-2F8E3167-68E8-4E87-B589-3643BF343D9FQ47100898-C9A21BEE-81EA-4A43-AA35-0AB83525702EQ47107950-1A27A2AD-68AD-460C-8895-DB63A126FEF4Q47145263-0279B655-0A13-4C55-8DC5-B3625E28AAF0Q47148725-B7439121-EE9D-48EE-9C0C-624063598842Q47262117-A4E7AE91-A3AE-42D4-8912-D6A84BE17B6EQ47964172-F155F4BB-969B-4242-97AC-F116B15D74E1Q49586369-5B7C1965-9845-442D-8737-6700994B1B5EQ49747284-9F8BC87A-9D84-4FA9-B180-459E5DC4761BQ50020595-B9082B63-55AF-49AE-835C-F718FB7233A7Q50128036-D2FD56B0-5052-4960-9C44-05F55A3E18DEQ50129785-B3750383-B292-452E-ABF2-7763F1CDB04AQ50305761-0A9E5B9E-7837-4B41-916D-B68AC63BAD3BQ51417301-59A3571B-DD4C-4204-8393-675F8EBC85A4Q52694946-25692DB0-D1E4-4C73-A6C0-9918C5815981Q53176393-62BBC84F-B95A-4C78-8609-9F9524649E8BQ53682879-95D84A91-1B6A-4BB8-A4B0-CD51308F981DQ55255678-F9B3550B-8F74-445F-83BB-6C0DED5E8139Q55455153-2B15D07B-D7E2-4E94-B34F-8CD15E0DD2A6Q58737364-CFD75A38-0FEC-4A1C-B9C7-1ACA284785E0Q58760411-CFF4A7F5-834C-4610-A603-25531BB99A01Q58775105-063CE597-6A15-447F-BA64-D8C17B41E078Q58781877-17C83FB3-1AB3-4709-98AB-89F720ECEC18
P2860
Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long intergenic non-coding RNA ...... p15 and p21 in gastric cancer.
@en
type
label
Long intergenic non-coding RNA ...... p15 and p21 in gastric cancer.
@en
prefLabel
Long intergenic non-coding RNA ...... p15 and p21 in gastric cancer.
@en
P2093
P2860
P356
P1433
P1476
Long intergenic non-coding RNA ...... p15 and p21 in gastric cancer.
@en
P2093
Dao-ping Sun
Er-bao Zhang
Ming-de Huang
Tong-peng Xu
Wen-ming Chen
Yong-qian Shu
P2860
P304
P356
10.18632/ONCOTARGET.6949
P407
P577
2016-01-19T00:00:00Z